Comparison of MicroRNA detection platforms.  Dr. Ioannis Ragoussis, Wellcome Trust Centre for Human Genetics, University of Oxford, UK . 
Methylome analysis using array and sequencing based approaches . Professor Stephan Beck, Cancer Institute, University College London, UK DNA methylation plays an essential role in biology with wide-ranging implications for human health and disease. To understand the rules governing DNA methylation and the consequences if DNA methylation is perturbed requires genome-wide analysis of its temporal and spatial plasticity. Almost 60 years after the discovery of 5-methyl cytosine and about 25 years since the discovery that altered DNA methylation plays a role in disease aetiology, particularly in cancer, technologies have finally become available for whole-genome DNA methylation profiling (methylome analysis) with ever increasing resolution. I will present data from our efforts using array- and sequencing-based platforms for high-throughput DNA methylation analysis, discuss some of the lessons learnt and give an outlook on how the data may be used in an integrated approach – termed ‘reverse phenotyping’ – to analyse and better understand the (epi)genomics of phenotypic plasticity in health and disease.
 
A comparison of expression profiling by deep sequencing and microarrays . Dr. Peter A.C. ‘t Hoen, Center for Human and Clinical Genetics, Leiden University Medical Center (LUMC),Leiden, The Netherlands